Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2012
05/24/2012US20120128665 Preselection of subjects for therapeutic treatment based on hypoxic status
05/24/2012US20120128660 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
05/24/2012US20120128659 Agents capable of downregulating an msf-a - dependent hif-1alpha and use thereof in cancer treatment
05/24/2012US20120128658 Rage g82s-related methods and compositions for treating inflammatory disorders
05/24/2012US20120128652 Endolysin plyp40
05/24/2012US20120128646 Methods and compositions for the treatment of autoimmune disease
05/24/2012US20120128642 Potency markers
05/24/2012US20120128632 Identity markers
05/24/2012US20120128626 Anti-il-6 antibodies for the treatment of anemia
05/24/2012US20120128592 Surface enhanced raman spectroscopy (sers) compounds and methods of their preparation
05/24/2012US20120128585 Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level
05/24/2012US20120128584 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
05/24/2012US20120128550 Method and a device for treating microparticles
05/24/2012US20120128536 Molecularly printed polymer for detecting the pentraxin, and method for preparing same
05/24/2012US20120128535 Bridged Element For Detection Of A Target Substance
05/24/2012US20120127224 Image registration on edible substrates
05/24/2012US20120126648 Machine and method for monitoring the state of a safety bearing of a machine
05/24/2012US20120125789 Enzyme stabilization in electrochemical sensors
05/24/2012US20120125788 Electrochemical affinity biosensor system and methods
05/24/2012US20120125774 Analysis Chip and Analysis Apparatus
05/24/2012US20120125773 Analysis Chip and Analysis Apparatus
05/24/2012US20120125767 Analyte Sensors and Methods of Use
05/24/2012US20120125086 Cartridge for body fluid measuring strips and a body fluid measurement device
05/24/2012US20120125082 Method of Selecting a Fragrance
05/24/2012US20120125079 Apparatus for on-line continuous chlorine analysis in turbid water and process streams
05/24/2012US20120125076 Portable metered flow apparatus for calibration/bump testing
05/24/2012DE202010017710U1 Vorrichtung zur Analyse flüssiger Proben An apparatus for analyzing liquid samples
05/24/2012DE10253917B4 Gassensor Gas sensor
05/24/2012DE102011119305A1 Material testing method for thermoplastic continuous fiber-reinforced semi-finished products, subjecting fiber assembly to material testing process, and executing test procedure under test conditions that meet semi-finished product test
05/24/2012DE102011086568A1 Amplifying signals in heterogeneous binding assays based on donor or receptor complex, comprises adding particle of first particle class and particle of second particle class to donor or receptor complex and optionally repeating steps
05/24/2012DE102011055265A1 Automatenfähiger Immunoassay für biogene Amine Machine-capable immunoassay for biogenic amines
05/24/2012DE102010051810A1 Bilderzeugende Massenspektrometrie mit Protein-Identifizierung An imaging mass spectrometry protein identification
05/24/2012DE102009043426B4 Vorrichtung und Verfahren zur Gewinnung, zum Nachweis und zur Analyse von Zellen in einem mikrofluidischen System Device and method for obtaining, for the detection and analysis of cells in a microfluidic system
05/24/2012DE102009000931B4 Verfahren zur Qualitätsbestimmung von zur Dacheindeckung vorgesehenem Reet sowie zur Prüfung von Verfahren zum prophylaktischen Reetschutz Method for determining the quality of the roofing thatch and the intended to examine procedures for prophylactic Reetschutz
05/24/2012DE102007048636B4 Marker zur Diagnose von Krebs Marker for diagnosing cancer
05/24/2012CA2845790A1 Determination of the thrombogenic power of human immunoglobulins
05/24/2012CA2818511A1 Device and method for measuring biomarkers
05/24/2012CA2818491A1 Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
05/24/2012CA2818486A1 Ncrna and uses thereof
05/24/2012CA2818234A1 Generation of neural stem cells from human trophoblast stem cells
05/24/2012CA2817887A1 Viability cell counting by differential light absorption
05/24/2012CA2817393A1 Use of quinolinone derivatives as a research tool
05/24/2012CA2817316A1 Device and method for immunotrials
05/24/2012CA2816645A1 A guided structured testing kit
05/24/2012CA2813451A1 Methods of diagnosing and treating neurodegenerative diseases
05/24/2012CA2787954A1 Biomarkers
05/24/2012CA2722722A1 Polar component detection
05/23/2012EP2455774A1 Sensor device and method for its operation
05/23/2012EP2455760A1 Analysis reagent and analysis device having the analysis reagent carried therein
05/23/2012EP2455759A1 Mass spectrometry imaging with substance identification
05/23/2012EP2455758A1 Method for measurement of glycoprotein, method for detection of hepatic diseases, reagent for quantification of glycoprotein, and sugar chain marker glycoprotein as measure of disease conditions of hepatic diseases
05/23/2012EP2455757A1 Method for strengthening signals in heterogeneous binding assays
05/23/2012EP2455756A1 Cell-based screening assay for inhibitors of NET formation
05/23/2012EP2455755A2 Proteaoglycan-4 as marker for chronic renal failure
05/23/2012EP2455751A1 Method for quantifying protein
05/23/2012EP2455750A1 Method for specific cleavage of n-c bond in peptide main chain
05/23/2012EP2455742A1 Improved dissolution test equipment
05/23/2012EP2455488A2 Methods and compositions for DNA manipulation
05/23/2012EP2455487A2 Chromatographic system for nucleic acid detection
05/23/2012EP2455469A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof
05/23/2012EP2455458A2 Covalent tethering of functional groups to proteins
05/23/2012EP2455457A2 Covalent tethering of functional groups to proteins
05/23/2012EP2455456A1 Use of kinesin inhibitors in HIV infection treatment and a method for screening them
05/23/2012EP2455397A1 Mutant ras polypeptide crystal
05/23/2012EP2455395A1 MCM6 monoclonal antibodies and methods for their use in the detection of cervical disease
05/23/2012EP2455389A1 Sugar chain marker as measure of disease conditions of hepatic diseases
05/23/2012EP2455163A1 Holding device for testing strip
05/23/2012EP2455100A2 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
05/23/2012EP2454599A1 INHIBITORS OF THE NITRATION OF AMYLOID ß PEPTIDES AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
05/23/2012EP2454598A1 Drug selection for gastric cancer therapy using antibody-based arrays
05/23/2012EP2454597A1 Therapeutic peptides, polypeptides ans nucleic acid sequences
05/23/2012EP2454596A1 Flap endonuclease-1 as a marker for cancer
05/23/2012EP2454595A1 Temperature-compensated in-vivo sensor
05/23/2012EP2454594A1 Use of animal cells for screening probiotic bacteria strains
05/23/2012EP2454593A1 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe)
05/23/2012EP2454592A1 Method and apparatus for determining an analyte parameter
05/23/2012EP2454591A2 New tool for studying endothelial haematopoietic transition (eht) and epithelial-mesenchymal transition (emt) associated events
05/23/2012EP2454590A2 A method of analyzing cellulose decay in cellulosic material hydrolysis
05/23/2012EP2454589A1 Method of assaying 5-fu
05/23/2012EP2454588A1 Nucleic acid analysis
05/23/2012EP2454587A2 Devices, methods, and kits for determining analyte concentrations
05/23/2012EP2454580A1 Method and apparatus for identifying the orientation of wood fibres
05/23/2012EP2454508A2 Flame safety system for in situ process analyzer
05/23/2012EP2454388A2 Methods and kits used in assessing cancer risk
05/23/2012EP2454387A1 Urinary trypsin inhibitors as diagnostic aid for interstitial cystitis
05/23/2012EP2454383A1 Znf217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in breast cancer
05/23/2012EP2454380A2 Diagnostic methods and compositions for treatment of cancer
05/23/2012EP2454379A1 Nucleic acid expression construct and its use as a cell proliferation marker
05/23/2012EP2454377A2 Mass spectrometric diagnosis of septicemia
05/23/2012EP2454372A2 Treatment and diagnosis of immune disorders
05/23/2012EP2454329A1 Novel fluorescent dyes and uses thereof
05/23/2012EP2454271A2 Peptides whose uptake in cells is controllable
05/23/2012EP2454269A1 Improved screening of biopolymers
05/23/2012EP2454261A1 Imidazo[1,2-alpha]pyrazin-3(7h)-one derivatives bearing a new electron-rich structure
05/23/2012EP2454260A1 Immunodetection and quantification of pyrazolopyrimidine sedatives
05/23/2012EP2454018A1 Tube for separating portions of a sample
05/23/2012EP2453926A2 Peptides whose uptake in cells is controllable
05/23/2012EP2453883A1 Method for predicting the utility of administering nicotinic acid or a precursor or prodrug thereof to reduce the severity of side-effects of cancer treatment with nicotinamide phosphoribosyltransferase inhibitors
05/23/2012EP2453871A1 Orally administered bacteria as vehicles for systemic delivery of agents
05/23/2012EP2453838A2 Cosmetic use of lacritin-type polypeptides